Lipid Nanoparticles Elicit Reactogenicity and Sickness Behavior in Mice Via Toll-Like Receptor 4 and Myeloid Differentiation Protein 88 Axis-Reference-Cited by-同舟云学术

Lipid Nanoparticles Elicit Reactogenicity and Sickness Behavior in Mice Via Toll-Like Receptor 4 and Myeloid Differentiation Protein 88 Axis

Published:2024-08-26 Issue:36 Volume:18 Page:24842-24859
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Korzun Tetiana¹²³,Moses Abraham S.¹,Jozic Antony¹^ORCID,Grigoriev Vladislav¹,Newton Samuel⁴,Kim Jeonghwan¹⁵^ORCID,Diba Parham³⁴,Sattler Ariana⁶,Levasseur Peter R.⁴,Le Ngoc¹,Singh Prem¹^ORCID,Sharma Kongbrailatpam Shitaljit¹,Goo Yoon Tae¹,Mamnoon Babak¹,Raitmayr Constanze¹,Mesquita Souza Ana Paula¹,Taratula Olena R.¹²,Sahay Gaurav¹^ORCID,Taratula Oleh¹^ORCID,Marks Daniel L.⁷

Affiliation:

1. Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, 2730 S Moody Avenue, Portland, Oregon 97201, United States

2. Department of Biomedical Engineering, Oregon Health & Science University, 3303 SW Bond Avenue, Portland, Oregon 97239, United States

3. Medical Scientist Training Program, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, Oregon 97239, United States

4. Papé Family Pediatric Research Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Mail Code L481, Portland, Oregon 97239, United States

5. College of Pharmacy, Yeungnam University, Gyeongsan 38541, Republic of Korea

6. Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, 2720 S Moody Avenue, Portland, Oregon 97201, United States

7. Endevica Bio, 1935 Techny Rd, Northbrook, Illinois 60062, United States

Funder

National Center for Advancing Translational Sciences

National Cancer Institute

Oregon Health and Science University

Knight Cancer Institute, Oregon Health and Science University

College of Pharmacy, Oregon State University

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.4c05088

Reference76 articles.

1. Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases

2. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

3. mRNA in the Context of Protein Replacement Therapy

4. mRNA-based cancer therapeutics

5. mRNA lipid nanoparticles induce immune tolerance to treat human diseases